Skip to main content Accessibility help
×
Home
  • Print publication year: 2015
  • Online publication date: August 2015

14 - Moyamoya disease and other non-atherosclerotic cerebral vasculopathies

1.Guidelines for diagnosis and treatment of moyamoya disease (Spontaneous Occlusion of the Circle of Willis). Neurol Med Chir 2012;52(5):245–66.
2.Ahn, IM, Park, DH, Hann, HJ, Kim, KH, Kim, HJ, Ahn, HS. Incidence, prevalence, and survival of moyamoya disease in Korea: a nationwide, population-based study. Stroke 2014;45(4):1090–5.
3.Scott, RM, Smith, ER. Moyamoya disease and moyamoya syndrome. N Engl J Med 2009;360(12):1226–37.
4.Kim, SK, Cho, BK, Phi, JH, et al. Pediatric moyamoya disease: an analysis of 410 consecutive cases. Ann Neurol 2010;68(1):92101.
5.Guzman, R., Lee, M, Achrol, A, et al. Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg 2009;111(5):927–35.
6.Scott, RM, Smith, JL, Robertson, RL, Madsen, JR, Soriano, SG, Rockoff, MA. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg 2004;100(2 Suppl Pediatrics):142–9.
7.Pandey, P, Steinberg, GK. Neurosurgical advances in the treatment of moyamoya disease. Stroke 2011;42(11):3304–10.
8.Rosser, TL, Vezina, G, Packer, RJ. Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1. Neurology 2005;64(3):553–5.
9.Kuroda, S, Houkin, K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol 2008;7(11):1056–66.
10.Herve, D, Touraine, P, Verloes, A, et al. A hereditary moyamoya syndrome with multisystemic manifestations. Neurology 2010;75(3):259–64.
11.Miskinyte, S, Butler, MG, Hervé, D, et al. Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya. Am J Hum Genet 2011;88(6):718–28.
12.Smith, ER, Scott, RM. Spontaneous occlusion of the circle of Willis in children: pediatric moyamoya summary with proposed evidence-based practice guidelines. A review. J Neurosurg Pediatr 2012;9(4):353–60.
13.Ezura, M, Yoshimoto, T, Fujiwara, S, Takahashi, A, Shirane, R, Mizoi, K. Clinical and angiographic follow-up of childhood-onset moyamoya disease. Childs Nerv Syst 1995;11(10):591–4.
14.Scott, RM, Smith, JL, Robertson, RL, Madsen, JR, Soriano, SG, Rockoff, MA. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg 2004;100(2 Suppl Pediatrics):S142–9.
15.Fung, L-WE, Thompson, D, Ganesan, V. Revascularisation surgery for paediatric moyamoya: a review of the literature. Childs Nerv Syst 2005;21(5):358–64.
16.Ng, J, Thompson, D, Lumley, JPS, Saunders, DE, Ganesan, V. Surgical revascularisation for childhood moyamoya. Childs Nerv Syst 2012;28(7):10418.
17.Park, EK, Lee, Y-H, Shim, K-W, Choi, J-U, Kim, D-S. Natural history and progression factors of unilateral moyamoya disease in pediatric patients. Childs Nerv Syst 2011;27(8):1281–7.
18.Roach, ES, Golomb, MR, Adams, R, et al. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke 2008;39(9):2644–91.
19.Switzer, JA, Hess, DC, Nichols, FT, Adams, RJ. Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol 2006;5(6):501–12.
20.Dobson, SR, Holden, KR, Nietert, PJ, et al. Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. Blood 2002;99(9):314450.
21.Chabriat, H, Joutel, A, Dichgans, M, Tournier-Lasserve, E, Bousser, MG. CADASIL. Lancet Neurol 2009;8(7):643–53.
22.Chabriat, H, Levy, C, Taillia, H, et al. Patterns of MRI lesions in CADASIL. Neurology 1998;51(2):452–7.
23.Joutel, A, Bousser, MG, Biousse, V, et al. A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet 1993;5(1):40–5.
24.Joutel, A, Vahedi, K, Corpechot, C, et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet 1997;350(9090):151115.
25.Buffon, F, Porcher R, Hernandez K, et al. Cognitive profile in CADASIL. J Neurol Neurosurg Psychiatry 2006;77(2):175–80.
26.Chabriat, H, Bousser, MG. Neuropsychiatric manifestations in CADASIL. Dialogues Clin Neurosci 2007;9(2):199208.
27.Epelbaum, S, Benisty, S, Reyes, S, et al. Verbal memory impairment in subcortical ischemic vascular disease: a descriptive analysis in CADASIL. Neurobiol Aging 2011;32(12):2172–82.
28.Jouvent, E, Reyes, S, Mangin, JF, et al. Apathy is related to cortex morphology in CADASIL. A sulcal-based morphometry study. Neurology 2011;76(17):1472–7.
29.Jouvent, E, Viswanathan, A, Mangin, JF, et al. Brain atrophy is related to lacunar lesions and tissue microstructural changes in CADASIL. Stroke 2007;38(6):1786–90.
30.Reyes, S, Viswanathan, A, Godin, O, et al. Apathy: a major symptom in CADASIL. Neurology 2009;72(10):905–10.
31.Viswanathan, A, Godin, O, Jouvent, E, et al. Impact of MRI markers in subcortical vascular dementia: a multi-modal analysis in CADASIL. Neurobiol Aging 2010;31(9):162936.
32.Yoneda, Y, Haginoya, K, Kato, M, et al., Phenotypic spectrum of COL4A1 mutations: porencephaly to schizencephaly. Ann Neurol, 2013;. 73(1): p. 4857.
33.Mine, M, Tournier-Lasserve, E. Intracerebral hemorrhage and COL4A1 mutations, from preterm infants to adult patients. Ann Neurol 2009;65(1):12.
34.Plaisier, E, Chen, Z, Gekeler, F, et al. Novel COL4A1 mutations associated with HANAC syndrome: a role for the triple helical CB3[IV] domain. Am J Med Genet A 2010;152A(10):2550–5.
35.Plaisier, E, Gribouval, O, Alamowitch, S, et al. COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. N Engl J Med 2007;357(26):2687–95.
36.Sibon, I, Coupry, I, Menegon, P, et al. COL4A1 mutation in Axenfeld-Rieger anomaly with leukoencephalopathy and stroke. Ann Neurol 2007;62(2):177–84.
37.Vahedi, K, Alamowitch, S. Clinical spectrum of type IV collagen (COL4A1) mutations: a novel genetic multisystem disease. Curr Opin Neurol 2011;24(1):63–8.
38.Vahedi, K, Kubis, N, Boukobza, M, et al. COL4A1 mutation in a patient with sporadic, recurrent intracerebral hemorrhage. Stroke 2007;38(5):1461–4.
39.Weng, YC, Sonni, A, Labelle-Dumais, C, et al. COL4A1 mutations in patients with sporadic late-onset intracerebral hemorrhage. Ann Neurol 2012;71(4):4707.